Related Experiment Video
Updated: Oct 19, 2025
08:48
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
3.0K
Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable
Alberto Alape-Girón1,2, Andrés Moreira-Soto3, Mauricio Arguedas1
1Instituto Clodomiro Picado, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica.
Frontiers in Medicine
|September 23, 2021
Abstract
No abstract available in PubMed .
Keywords:
COVID-19SARS-CoV-2convalescent plasmaheterologous antibodieshyperimmune polyclonal antibodiesmonoclonal antibodiespassive immunotherapyMore Related Videos
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
17.4K
08:21Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera
Published on: May 23, 2025
573
Related Concept Videos
01:31Hybridoma Technology
16.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
16.0K
00:42Cross-reactivity
31.8K
Overview
31.8K
01:36Humoral Immune Responses
78.3K
Overview
78.3K